A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa

Condition:   Lassa Fever Interventions:   Drug: Day 1 Lower Dose (2×106 pfu);   Drug: Day 1 Higher Dose (1×107 pfu);   Drug: Placebo Sponsors:   International AIDS Vaccine Initiative;   Coalition for Epidemic Preparedness Innovations Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials